Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

 v2.3.0.11
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Operating activities    
Net income (loss) $ 8,576 $ (3,034)
Less: gain from discontinued operations 4 246
Income (loss) from continuing operations 8,572 (3,280)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Accretion of deferred gain on sale leaseback (851) (851)
Change in estimated fair value of contingent value rights 1,057 (4,242)
Depreciation and amortization 1,349 1,448
Non-cash lease costs (135) (64)
Gain on asset write-offs 1 (64)
Realized gain on investment 6 (564)
Stock-based compensation 1,696 1,457
Deferred income taxes (13,783) 0
Other 102 27
Changes in operating assets and liabilities, net of acquisition:    
Accounts receivable, net 1,157 618
Inventory (179) 0
Other current assets 4,340 (66)
Other long term assets 570 (413)
Accounts payable and accrued liabilities (8,183) (8,032)
Other liabilities (1,636) (1,055)
Deferred revenue (1,217) (3,275)
Net cash used in operating activities of continuing operations (7,134) (18,356)
Net cash provided by operating activities of discontinued operations 0 263
Net cash used in operating activities (7,134) (18,093)
Investing activities    
Purchases of property and equipment (5) (65)
Acquisition of CyDex, net of cash acquired (32,024) 0
Acquisition of Metabasis, net of cash acquired 0 (2,834)
Acquisition of intellectual property 0 (1,375)
Purchases of short-term investments (10,000) (31,861)
Proceeds from sale of short-term investments 19,346 40,667
Proceeds from sale of property and equipment and building 0 205
Other, net (33) 499
Net cash provide by (used in) investing activities of continuing operations (22,716) 5,236
Net cash provided by investing activities of discontinued operations 0 0
Net cash provided by (used in) investing activities (22,716) 5,236
Financing activities    
Proceeds from issuance of debt 30,000 0
Share repurchases (55) 0
Principal payments on equipment financing obligations 0 (52)
Net proceeds from issuance of common stock 0 112
Net cash provided by financing activities 29,945 60
Net increase (decrease) in cash and cash equivalents 95 (12,797)
Cash and cash equivalents at beginning of period 3,346 16,032
Cash and cash equivalents at end of period $ 3,441 $ 3,235